Administration of antibiotic and antifungal substances in prophylaxis and therapy for major abdominal surgery;Einsatz von antibiotika und antimykotika in prophylaxe und therapie bei großen viszeralchirurgischen eingriffen

Viszeralmedizin: Gastrointestinal Medicine and Surgery

Volumn 27, Issue 1, 2011, Pages 50-57

  Eckmann, Christian ^a  

^a Klinikum Peine   (Germany)

Author keywords

Abdominal surgery; Antibiotic prophylaxis; Antibiotic treatment; Antifungal treatment; Peritonitis; Vaccination for splenectomy

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAPENEM DERIVATIVE; ECHINOCANDIN; EXTENDED SPECTRUM BETA LACTAMASE; FLUCONAZOLE; HAEMOPHILUS INFLUENZAE VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; TIGECYCLINE;

ABDOMINAL SURGERY; ARTICLE; BACTERIUM ISOLATION; ENTEROBACTERIACEAE; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFECTION; HUMAN; INFECTION PREVENTION; MENINGOCOCCOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOSIS; PNEUMOCOCCAL INFECTION; PREOPERATIVE CARE; SPLENECTOMY; SURGICAL INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 79952511211     PISSN: 16626664     EISSN: 16626672     Source Type: Journal    
DOI: 10.1159/000324306     Document Type: Article

References (42)

1. Bruch HP, Schimmelpenning H, Eckmann C: Antibiotikaprophylaxe in der Viszeralchirurgie. Chirurg 1997;20:951-955.
2. Wacha H, Hoyme U, Isenmann R, Kujath P, Lebert C, Naber K, Salzberger B: Perioperative Antibiotika- Prophylaxe. Chemother J 2010;19:70-84.
3. Claasen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP: The timing of prophylactic administration of antibiotics and the risk for surgical-wound infection. N Eng J Med 1992; 326:281-286.
4. Weber WP, Marti WR, Zwahlen M, Misteli H, Rosenthal R, Reck S, Fueglistaler P, Bolli M, Trampuz A, Oertli D, Widmer AF: The timing of surgical antimicrobial prophylaxis. Ann Surg 2008;247:918-926. (Pubitemid 351770411)
5. Mohri Y, Tonouchi H, Kobayashi M, Nakai K, Kusunoki M; Mie Surgical Infection Research Group: Randomized clinical trial of single- versus multipledose antimicrobial prophylaxis in gastric cancer surgery. Br J Surg 2007;94:683-688. (Pubitemid 46910059)
6. Bisharat N, Omari H, Lavi I, Raz R: Risk of infection and death among post-splenectomy patients. J Infect 2001;43:182-186. (Pubitemid 34211099)
7. Cumbria & Lancashire Health Protection Unit NHS Splenectomy Guidelines June 2002: Guidance on the Prevention of Infections in Asplenic Patients or Patients with a Dysfunctional Spleen. www.healthprotection.org.uk .
8. Engelhardt M, Haas PS, Theilacker C, Eber SW, Schmugge M, Kern WV, Heimpel H: Pr?ention von Infektionen und Thrombosen nach Splenektomie oder bei Funktionsverlust der Milz. DMW 2009;134:897-902.
9. Kyaw MH, Holmes EM, Toolis F, Wayne B, Chalmers J, Jones IG, Campbell H: Evaluation of severe infection and survival after splenectomy. Am J Med 2006;110:276.e1-276.e7.
10. Bader F, Schroeder M, Kujath P, Muhl E, Bruch HP, Eckmann C: Diffuse postoperative peritonitis - value of diagnostic parameters and impact of early indication for relaparotomy. Eur J Med Res 2009;14:1-6.
11. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K: Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 2007;33:606-618. (Pubitemid 46474888)
12. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-1596. (Pubitemid 43810035)
13. Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ: Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev 2005;18:CD004539.
14. Barie P: The cost of failure. Surg Infect 2008;9:313-315. (Pubitemid 351873417)
15. Nathans AB, Cook CH, Machiedo G, Moore EE, Namias N, Nwariaku F: Defining the research agenda for surgical infection: a consensus of experts using the Delphi approach. Surg Infect (Larchmt) 2006;7:101-109.
16. Dryden M: Complicated skin and soft tissue infection. J Antimicrob Chemother 2010;65(suppl 3):iii35-44.
17. Nathwani D: New antibiotics for the management of complicated skin and soft tissue infections: are they any better? Int J Antimicrob Agents 2009; 34:S24-29.
18. Eckmann C, Dryden M: Treatment of complicated skin and soft tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin. Eur J Med Res 2010;15:554-563.
19. Pankey GA, Sabath LD: Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of grampositive bacterial infections. Clin Infect Dis 2004;38:864-870. (Pubitemid 38387236)
20. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG: Diagnosis and management of complicated intra-abdominal infections in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133-164.
21. Bodmann KF, Grabein B, Expertenkommission der Paul-Ehrlich-Gesellschaft f Chemotherapie e.V.: Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Rheinbach, Paul-Ehrlich-Gesellschaft f Chemotherapie e.V., 2010, pp 181-187.
22. Kujath P, Rodloff AC: Peritonitis, ed 2. Heidelberg, Uni-Med, 2005, pp 13-15.
23. Weigelt JA: Empiric treatment options in the management of complicated intra-abdominal infections. Cleve Clin J Med 2007;74(suppl 4):S29-37.
24. Chavez-Tapia NC, Soares-Weiser K, Brezis N, Leibovis L: Antibiotics for spontanaeous bacterial peritonitis in cirrhotic patients. Cochrane Database Syst Rev 2009;3:CD002232.
25. Eckmann C, Isenmann R, Kujath P, Pross A, Rodloff AC, Schmitz F-J, Trautmann M, Wacha H: l. Intraabdominelle Infektionen; in Bodmann KF, Grabein B, Expertenkommission der Paul-Ehrlich- Gesellschaft f Chemotherapie e.V.: Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Rheinbach, Paul-Ehrlich-Gesellschaft f Chemotherapie e.V., 2010, pp 46-52.
26. Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Leibovici L: Beta lactam antibiotic monotherapy versus lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 2006;25:CD003344.
27. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E; Tigecycline 301 Study Group; Tigecycline 306 Study Group: The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical data. Clin Infect Dis 2005;41:354-367.
28. Bassetti M, Nicolini L, Repetto E, Righi E, Del Bono V, Viscoli C: Tigecycline use in serious mosocomial infections: a drug use evaluation. BMC Infect Dis 2010;10:287.
29. Eckmann C, Heizmann WR, von Eiff C, Leitner E, L?chmann PA, Bodmann KF: Prospective, noninterventional multicentre trial of tigecycline in the treatment of severely ill patients. Chemother J 2010;19:165-166.
30. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T: Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066-1072. (Pubitemid 29314312)
31. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA: Doubleblind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001;233:542-548. (Pubitemid 32234953)
32. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America: Clinical practise guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-535.
33. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J: Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12.
34. De Waele JJ: A role for prophylactic antibiotics in necrotizing pancreatitis? Crit Care 2008;12:195.
35. Augustin P, Kermarrec N, Muller-Serieys C, Montravers P: Risk factors for multi-drug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care 2010;14:R20.
36. www.fda.gov/Drugs/DrugSafety/ucm224370.htmhttp://www.fda.gov/Drugs/ DrugSafety/ucm224370.htm, www.fda.gov/Drugs/DrugSafety/ucm224370.htm
37. Swoboda S, Ober M, Hainer C, Lichtenstern C, Seiler C, Wendt C, Hoppe-Tichy T, Bhler M, Weigand MA: Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug evaluation in a surgical intensive care unit. J Antimicrob Chemother 2008;61:729-733. (Pubitemid 351321153)
38. Birmingham MC, Rayner CR, Meagher AM, Flavin SM, Batts DH, Schentag JJ: Linezolid in the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis 2003;36:159-168. (Pubitemid 36143412)
39. Nickols RL, Muzik AC: Enterococcal infections in surgical patiens: the mystery continues. Clin Infect Dis 1992;15:72-76.
40. Lehner S, Grabein B, Pfaller P, Kopp R: BedeutungESBL-produzierender Keime f die klinische Chirurgie. Chirurg 2009;80:527-532.
41. Villatore E, Bassi C, Larvin M: Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2006;4:CD002941.
42. Mazaki T, Ishii Y, Takayama T: Meta-analysis of prophylactic use in acute necrotizing pancreatitis. Br J Surg 2006;93:674-684. (Pubitemid 43886018)